Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension

被引:3
|
作者
Okninska, Marta [1 ]
Zajda, Karolina [2 ]
Zambrowska, Zuzanna [1 ]
Grzanka, Malgorzata [3 ]
Paterek, Aleksandra [1 ]
Mackiewicz, Urszula [1 ]
Szczylik, Cezary [4 ]
Kurzyna, Marcin [5 ]
Piekielko-Witkowska, Agnieszka [3 ]
Torbicki, Adam [5 ]
Kieda, Claudine [2 ,6 ,7 ]
Maczewski, Michal [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Clin Physiol, Marymoncka Str 99-103, PL-01813 Warsaw, Poland
[2] Mil Med Inst, Lab Mol Oncol & Innovat Therapies, Warsaw, Poland
[3] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland
[4] Ctr Postgrad Med Educ, Dept Oncol ECZ Otwock, Warsaw, Poland
[5] Ctr Postgrad Med Educ, Dept Pulm Circulat Thromboembol Dis & Cardiol ECZ, Warsaw, Poland
[6] Ctr Mol Biophys, UPR, CNRS 4301, Orleans, France
[7] Ctr Postgrad Med Educ, Dept Mol & Translat Oncol, Warsaw, Poland
关键词
angiogenesis; hypertrophy; oxygen deficiency; pulmonary arterial hypertension; right ventricular failure;
D O I
10.1016/j.jchf.2023.03.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Right ventricular (RV) function and eventually failure determine outcome in patients with pulmonary arterial hypertension (PAH). Initially, RV responds to an increased load caused by PAH with adaptive hypertrophy; however, eventually RV failure ensues. Unfortunately, it is unclear what causes the transition from compensated RV hypertrophy to decompensated RV failure. Moreover, at present, there are no therapies for RV failure; those for left ventricular (LV) failure are ineffective, and no therapies specifically targeting RV are available. Thus there is a clear need for understanding the biology of RV failure and differences in physiology and pathophysiology between RV and LV that can ultimately lead to development of such therapies. In this paper, we discuss RV adaptation and maladaptation in PAH, with a particular focus of oxygen delivery and hypoxia as the principal drivers of RV hypertrophy and failure, and attempt to pinpoint potential sites for therapy. (J Am Coll Cardiol HF 2024;12:235-247) (c) 2024 by the American College of Cardiology Foundation.
引用
收藏
页码:235 / 247
页数:13
相关论文
共 50 条
  • [1] Emerging role of epigenetic in pulmonary arterial hypertension right ventricular failure
    Potus, Francois
    Ruffenach, Gregoire
    Provencher, Steeve
    Bonnet, Sebastien
    FASEB JOURNAL, 2015, 29
  • [2] Pathobiology of pulmonary arterial hypertension and right ventricular failure
    Voelkel, Norbert F.
    Gomez-Arroyo, Jose
    Abbate, Antonio
    Bogaard, Harm J.
    Nicolls, Mark R.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (06) : 1555 - 1565
  • [3] INOTROPES FOR RIGHT VENTRICULAR FAILURE IN PULMONARY ARTERIAL HYPERTENSION
    Odeyemi, Yewande
    Dhungana, Prabij
    Dubrock, Hilary
    CHEST, 2018, 154 (04) : 1038A - 1038A
  • [4] Right Ventricular Adaptation and Failure in Pulmonary Arterial Hypertension
    Ryan, John J.
    Huston, Jessica
    Kutty, Shelby
    Hatton, Nathan D.
    Bowman, Lindsay
    Tian, Lian
    Herr, Julia E.
    Johri, Amer M.
    Archer, Stephen L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (04) : 391 - 406
  • [5] Epigenetic signature of right ventricular failure in pulmonary arterial hypertension
    Potus, Francois
    Michelakis, Evangelos
    Provencher, Steeve
    Bonnet, Sebastien
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] Proteomic Signature of Right Ventricular Failure in Pulmonary Arterial Hypertension
    Yokokawa, Tetsuro
    Shimauchi, Tsukasa
    Bonnet, Sandra B.
    Potus, Francois
    Paulin, Roxane
    Provencher, Steeve
    Bonnet, Sebastien
    Boucherat, Olivier
    CIRCULATION, 2021, 144
  • [7] Right Ventricular Failure in Idiopathic Pulmonary Arterial Hypertension Is Associated With Inefficient Myocardial Oxygen Utilization
    Wong, Yeun Ying
    Ruiter, Gerrina
    Lubberink, Mark
    Raijmakers, Pieter G.
    Knaapen, Paul
    Marcus, J. Tim
    Boonstra, Anco
    Lammertsma, Adriaan A.
    Westerhof, Nico
    van der Laarse, Willem J.
    Vonk-Noordegraaf, Anton
    CIRCULATION-HEART FAILURE, 2011, 4 (06) : 700 - U70
  • [8] The Role of the NLRP3 Inflammasome and Macrophages in Right Ventricular Failure in Pulmonary Arterial Hypertension
    Ai-Qazazi, R.
    Lima, P. D.
    Tian, L.
    Potus, F.
    Das Gupta, A.
    Chen, K.
    Neuber-Hess, M.
    Mewburn, J.
    Archer, S. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Pulmonary Arterial Hypertension With Right Ventricular Failure The Left Forgotten Ventricle
    Freed, Benjamin H.
    Gomberg-Maitland, Mardi
    CHEST, 2013, 144 (05) : 1435 - 1436
  • [10] Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension
    Jimenez Cabrera, Oscar Gabriel
    Rene Pulido-Zamudio, Tomas
    Guadalupe Zayas-Hernandez, Nayeli
    Cesar Lopez-Reyes, Julio
    Sandoval-Zarate, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54